Abstract
Gliomas are the most frequent primary brain tumors in humans. Many studies have been carried out on their etiology; however, the only confirmed risk factors are hereditary predisposing conditions and high dose of ionizing radiation. Recently, human cytomegalovirus (HCMV) gene products and nucleic acids were reported to be present in all of 27 glioma samples investigated in contrast to other brain tissues, and it was hypothesized that HCMV might play a role in glioma pathogenesis. To evaluate these findings, samples of 40 gliomas, 31 meningiomas, and 6 acoustic neurinomas (ACNs) were analyzed for the presence of HCMV macromolecules using polymerase chain reaction (PCR) and immunohistochemistry. Additionally, corresponding blood samples from 72 patients were analyzed for the presence of HCMV DNA to check for a possible contamination of tumor tissues with HCMV-infected blood cells. No HCMV DNA sequences were found, neither in brain tumor tissues nor in corresponding blood samples. Immunohistochemistry did not detect HCMV-specific proteins. Addressing a possible role of other herpesviruses as has been suggested in seroepidemiological studies, seroprevalences of antibodies to HCMV, herpes simplex virus (HSV), Epstein-Barr virus (EBV), and varicella-zoster virus (VZV) were determined by enzyme-linked immunosorbent assay (ELISA). Serological analyses of brain tumor patients showed no significant differences in the prevalences of antibodies to HCMV, HSV, EBV, or VZV compared to the general population. Thus, the data of the present study do not support the hypothesis of an association of herpesviruses with the development of primary brain tumors.
Similar content being viewed by others
References
Becker N (1998). Atlas of cancer mortality in the Federal Republic of Germany. Berlin, Heidelberg: Springer.
Bondy ML, Wrensch MR (1996). Epidemiology of primary malignant brain tumours. Baillieres Clin Neurol 5: 251–270.
Britt W, Alford C (1996). Cytomegalovirus. In: Fields virology. Fields B, Knipe D, Howley P (eds). Philadelphia: Lippincott-Raven Publishers, pp 2493–2523.
Castillo JP, Kowalik TF (2002). Human cytomegalovirus immediate early proteins and cell growth control. Gene 290: 19–34.
Castillo JP, Yurochko AD, Kowalik TF (2000). Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol 74: 8028–8037.
Chee M, Rudolph SA, Plachter B, Barrell B, Jahn G (1989). Identification of the major capsid protein gene of human cytomegalovirus. J Virol 63: 1345–1353.
Cinatl J, Jr, Scholz M, Doerr HW (2005). Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation. Med Res Rev 25: 167–185.
Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002). Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62: 3347–3350.
Cohen JI (2000). Epstein-Barr virus infection. N Engl J Med 343: 481–492.
Doniger J, Muralidhar S, Rosenthal LJ (1999). Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev 12: 367–382.
Fritschy JM, Brandner S, Aguzzi A, Koedood M, Luscher B, Mitchell PJ (1996). Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice. J Neurosci 16: 2275–2282.
Gass P, Kiessling M, Schafer P, Mester C, Schmitt HP, Kuhn JE (1993). Detection of human cytomegalovirus DNA in paraffin sections of human brain by polymerase chain reaction and the occurrence of false negative results. J Neurol Neurosurg Psychiatry 56: 211–214.
Hadfield MG, Murray BK, Thomson TA, Young HF (1984). Herpesvirus type 1 serum antibodies and brain tumors in humans. Clin Neuropathol 3: 68–71.
Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS (2002). Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360: 1557–1563.
Hellenbrand W, Thierfelder W, Muller-Pebody B, Hamouda O, Breuer T (2005). Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997–1998. Eur J Clin Microbiol Infect Dis 24: 131–135.
Herrero YC, Cornelis JJ, Herold-Mende C, Rommelaere J, Schlehofer JR, Geletneky K (2004). Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing. Int J Cancer 109: 76–84.
Ho M (1990). Epidemiology of cytomegalovirus infections. Rev Infect Dis 12 (Suppl 7): S701-S710.
Huang G, Yan Q, Wang Z, Chen X, Zhang X, Guo Y, Li JJ (2002). Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin’s disease. Int J Oncol 21: 31–36.
Inskip PD, Linet MS, Heineman EF (1995). Etiology of brain tumors in adults. Epidemiol Rev 17: 382–414.
Knosel T, Schewe C, Dietel M, Petersen I (2004). Cytomegalovirus is not associated with progression and metastasis of colorectal cancer. Cancer Lett 211: 243–247.
Krech U (1973). Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ 49: 103–106.
Landolfo S, Gariglio M, Gribaudo G, Lembo D (2003). The human cytomegalovirus. Pharmacol Ther 98: 269–297.
Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM (2005). Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18: 838–843.
Lokensgard JR, Cheeran MC, Gekker G, Hu S, Chao CC, Peterson PK (1999). Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J Hum Virol 2: 91–101.
Mangano M, Hodinka R, Spivack J (1992). Detection of human cytomegalovirus by polymerase chain reaction. In: Diagnosis of human viruses by polymerase chain reaction technology. Becker G, Darai G (eds). Berlin New York: Springer-Verlag, pp 147–156.
Menegoz F, Little J, Colonna M, Arslan A, Preston-Martin S, Schlehofer B, Blettner M, Howe GR, Ryan P, Giles GG, Rodvall Y, Choi WN (2002). Contacts with animals and humans as risk factors for adult brain tumours. An international case-control study. Eur J Cancer 38: 696–704.
Menet A, Speth C, Larcher C, Prodinger WM, Schwendinger MG, Chan P, Jager M, Schwarzmann F, Recheis H, Fontaine M, Dierich MP (1999). Epstein-Barr virus infection of human astrocyte cell lines. J Virol 73: 7722–7733.
Mocarski ES Jr (2002). Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10: 332–339.
Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B (2004). Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 14: 453–471.
Preston-Martin S, Mack W (1996). Neoplasms of the nervous system. In: Cancer epidemiology and prevention. Schottenfield D, Fraumeni J (eds). New York: Oxford University Press, pp 1231–1291.
Preston-Martin S, Pogoda JM, Schlehofer B, Blettner M, Howe GR, Ryan P, Menegoz F, Giles GG, Rodvall Y, Choi NW, Little J, Arslan A (1998). An international case-control study of adult glioma and meningioma: the role of head trauma. Int J Epidemiol 27: 579–586.
Rabenau HF, Buxbaum S, Preiser W, Weber B, Doerr HW (2002). Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol (Berl) 190: 153–160.
RKI. (2000a). Humanes Cytomegalievirus (HCMV); Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit. Bundesgesundheitsblatt 70: 653–659.
RKI. (2000b). Varizellen, Herpes Zoster. Epidemiol Bull 46: 368–369.
Rollison DE, Helzlsouer KJ, Alberg AJ, Hoffman S, Hou J, Daniel R, Shah KV, Major EO (2003). Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev 12: 460–463.
Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Tremoulet M, Delisle MB, Brousset P (2005). Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92: 747–750.
Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS (2003). High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170: 998–1002.
Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J (1992). Medical risk factors and the development of brain tumors. Cancer 69: 2541–2547.
Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F, Ryan P (1999). Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82: 155–160.
Smith KO, Newman JT, Story JL, Wissinger JP (1974). Viruses and brain tumors. Clin Neurosurg 21: 362–382.
Wohlrabe P, Sprossig M, Farber I, Wutzler P, Steube D, Schreiber D (1984). Virologisch-serologische Untersuchungen bei Patienten mit Hirntumoren. Zentralbl Neurochir 45: 152–158.
Wolff D, Sinzger C, Drescher P, Jahn G, Plachter B (1994). Reduced levels of IE2 gene expression and shutdown of early and late viral genes during latent infection of the glioblastoma cell line U138-MG with selectable recombinants of human cytomegalovirus. Virology 204: 101–113.
Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002). Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-oncol 4: 278–299.
Wrensch M, Weinberg A, Wiencke J, Masters H, Miike R, Barger G, Lee M (1997). Does prior infection with varicella-zoster virus influence risk of adult glioma? Am J Epidemiol 145: 594–597.
Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K (2001). Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol 154: 161–165.
Wutzler P, Doerr HW, Farber I, Eichhorn U, Helbig B, Sauerbrei A, Brandstadt A, Rabenau HF (2000). Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol 61: 201–207.
Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A (2001). Seroprevalence of varicella-zoster virus in the German population. Vaccine 20: 121–124.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was authorized by the local ethics commission.
This research was supported by the German Research Foundation (DFG) under the Graduiertenkolleg 793.
Rights and permissions
About this article
Cite this article
Poltermann, S., Schlehofer, B., Steindorf, K. et al. Lack of association of herpesviruses with brain tumors. Journal of NeuroVirology 12, 90–99 (2006). https://doi.org/10.1080/13550280600654573
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280600654573